Ju Hoon Oh

570 total citations
10 papers, 478 citations indexed

About

Ju Hoon Oh is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Ju Hoon Oh has authored 10 papers receiving a total of 478 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Cancer Research and 2 papers in Surgery. Recurrent topics in Ju Hoon Oh's work include Spinal Hematomas and Complications (2 papers), Magnolia and Illicium research (2 papers) and Cancer-related Molecular Pathways (2 papers). Ju Hoon Oh is often cited by papers focused on Spinal Hematomas and Complications (2 papers), Magnolia and Illicium research (2 papers) and Cancer-related Molecular Pathways (2 papers). Ju Hoon Oh collaborates with scholars based in South Korea, United States and Japan. Ju Hoon Oh's co-authors include Jin Tae Hong, Sang‐Bae Han, Jung Ok Ban, Dong Cheul Moon, Myoung Suk Choi, Heon‐Sang Jeong, Tae Myoung Kim, Dae Joong Kim, Hwan Soo Yoo and Yong‐Moon Lee and has published in prestigious journals such as Molecular Cancer Therapeutics, Arthritis Research & Therapy and Neuroscience Letters.

In The Last Decade

Ju Hoon Oh

10 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ju Hoon Oh South Korea 9 228 171 102 87 80 10 478
An‐Chin Cheng Taiwan 13 292 1.3× 72 0.4× 98 1.0× 58 0.7× 99 1.2× 22 538
Gyeoung-Jin Kang South Korea 17 288 1.3× 84 0.5× 45 0.4× 77 0.9× 57 0.7× 39 710
Chong Kil Lee South Korea 17 330 1.4× 200 1.2× 159 1.6× 48 0.6× 223 2.8× 30 863
Koteswara Rao Nalamolu United States 14 182 0.8× 66 0.4× 58 0.6× 111 1.3× 122 1.5× 28 655
Yasutaka Ikeda Japan 11 527 2.3× 60 0.4× 96 0.9× 54 0.6× 96 1.2× 17 833
Yewseok Suh United States 10 377 1.7× 104 0.6× 35 0.3× 59 0.7× 74 0.9× 14 661
Yeong S. Kim South Korea 8 252 1.1× 87 0.5× 59 0.6× 24 0.3× 58 0.7× 9 540
You-Jin Kang South Korea 8 313 1.4× 51 0.3× 53 0.5× 32 0.4× 49 0.6× 11 509
Mei‐Feng Hsu Taiwan 14 274 1.2× 81 0.5× 108 1.1× 21 0.2× 75 0.9× 35 608
Hong-Kun Rim South Korea 16 308 1.4× 83 0.5× 71 0.7× 43 0.5× 100 1.3× 30 649

Countries citing papers authored by Ju Hoon Oh

Since Specialization
Citations

This map shows the geographic impact of Ju Hoon Oh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju Hoon Oh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju Hoon Oh more than expected).

Fields of papers citing papers by Ju Hoon Oh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ju Hoon Oh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju Hoon Oh. The network helps show where Ju Hoon Oh may publish in the future.

Co-authorship network of co-authors of Ju Hoon Oh

This figure shows the co-authorship network connecting the top 25 collaborators of Ju Hoon Oh. A scholar is included among the top collaborators of Ju Hoon Oh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ju Hoon Oh. Ju Hoon Oh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Oh, Ju Hoon, Eun Young Kim, Yeon‐Joo Lee, et al.. (2019). Synergistic Autophagy Effect of miR-212-3p in Zoledronic Acid-Treated In Vitro and Orthotopic In Vivo Models and in Patient-Derived Osteosarcoma Cells. Cancers. 11(11). 1812–1812. 11 indexed citations
2.
Oh, Ju Hoon, Jung Ok Ban, Min Cho, et al.. (2011). 4-O-methylhonokiol inhibits colon tumor growth via p21-mediated suppression of NF-κB activity. The Journal of Nutritional Biochemistry. 23(7). 706–715. 17 indexed citations
3.
Oh, Ju Hoon, Hwan‐Soo Yoo, Yong-Moon Lee, et al.. (2010). (−)-Epigallocatechin-3-O-gallate (EGCG) reverses caffeine-induced anxiogenic-like effects. Neuroscience Letters. 481(2). 131–134. 31 indexed citations
4.
Ban, Jung Ok, Dong Hoon Kwak, Ju Hoon Oh, et al.. (2010). Suppression of NF-κB and GSK-3β is involved in colon cancer cell growth inhibition by the PPAR agonist troglitazone. Chemico-Biological Interactions. 188(1). 75–85. 78 indexed citations
5.
Oh, Ju Hoon, et al.. (2009). Anti-inflammatory effect of 4-O-methylhonokiol, a novel compound isolated from Magnolia officinalis through inhibition of NF-κB. Chemico-Biological Interactions. 180(3). 506–514. 57 indexed citations
6.
Ban, Jung Ok, Ju Hoon Oh, Tae Myoung Kim, et al.. (2009). Anti-inflammatory and arthritic effects of thiacremonone, a novel sulfurcompound isolated from garlic via inhibition of NF-κB. Arthritis Research & Therapy. 11(5). R145–R145. 88 indexed citations
7.
Choi, Myoung Suk, Ju Hoon Oh, Sun Mi Kim, et al.. (2009). Berberine inhibits p53-dependent cell growth through induction of apoptosis of prostate cancer cells.. PubMed. 34(5). 1221–30. 93 indexed citations
8.
Ban, Jung Ok, Ju Hoon Oh, Bang Yeon Hwang, et al.. (2009). Inflexinol inhibits colon cancer cell growth through inhibition of nuclear factor-κB activity via direct interaction with p50. Molecular Cancer Therapeutics. 8(6). 1613–1624. 29 indexed citations
9.
Choi, Myoung Suk, Dong Yeon Yuk, Ju Hoon Oh, et al.. (2009). Berberine inhibits human neuroblastoma cell growth through induction of p53-dependent apoptosis.. PubMed. 28(6A). 3777–84. 69 indexed citations
10.
Christ, D., Ju Hoon Oh, & Howard J. Saz. (1994). Contractions of the filariidAcanthocheilonema viteae induced by potassium chloride. Parasitology Research. 80(6). 449–453. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026